Evidence map›Paper›PMID 35609248›Full record

ArticleAnalytical chemistry2022

Accurate Prediction of y Ions in Beam-Type Collision-Induced Dissociation Using Deep Learning.

HyeonSeok Shin, Youngmin Park, Kyunggeun Ahn, Sungsoo Kim

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

HyeonSeok ShinBio Convergence Research Institute, Bertis Inc., Heungdeok 1-ro, Giheung-gu, Yongin-si, 16954 Gyeonggi-do, Republic of Korea.ORCID 0000-0001-7618-035X
Youngmin ParkBio Convergence Research Institute, Bertis Inc., Heungdeok 1-ro, Giheung-gu, Yongin-si, 16954 Gyeonggi-do, Republic of Korea.
Kyunggeun AhnBio Convergence Research Institute, Bertis Inc., Heungdeok 1-ro, Giheung-gu, Yongin-si, 16954 Gyeonggi-do, Republic of Korea.
Sungsoo KimBio Convergence Research Institute, Bertis Inc., Heungdeok 1-ro, Giheung-gu, Yongin-si, 16954 Gyeonggi-do, Republic of Korea.ORCID 0000-0003-1870-3495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide fragmentation spectra contain critical information for the identification of peptides by mass spectrometry. In this study, we developed an algorithm that more accurately predicts the high-intensity peaks among the peptide spectra. The training data are composed of 180,833 peptides from the National Institute of Standards and Technology and Proteomics Identification database, which were fragmented by either quadrupole time-of-flight or triple-quadrupole collision-induced dissociation methods. Exploratory analysis of the peptide fragmentation pattern was focused on the highest intensity peaks that showed proline, peptide length, and a sliding window of four amino acid combination that can be exploited as key features. The amino acid sequence of each peptide and each of the key features were allocated to different layers of the model, where recurrent neural network, convolutional neural network, and fully connected neural network were used. The trained model, PrAI-frag, accurately predicts the fragmentation spectra compared to previous machine learning-based prediction algorithms. The model excels at high-intensity peak prediction, which is advantageous to selective/multiple reaction monitoring application. PrAI-frag is provided via a Web server which can be used for peptides of length 6-15.

Indexed as

Deep LearningTandem Mass SpectrometryIonsPeptidesProteomicsIonsPeptides

Identifiers

PMID35609248
PMCPMC9178553
OpenAlexW4281836560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.